Resolution of the Research Council of Experts on the place of netakimab, a new interleukin-17a inhibitor, in the therapy of ankylosing spondylitis
For citations:
Resolution of the Research Council of Experts on the place of netakimab, a new interleukin-17a inhibitor, in the therapy of ankylosing spondylitis. Rheumatology Science and Practice. 2020;58(3):347. (In Russ.)
Views:
301
Email this article 